Storage-dependent variability in Alzheimer disease-related plasma biomarker results using the Fujirebio Lumipulse G1200 platform
Journal of Neuropathology & Experimental Neurology · 01.12.2025 · 84 (12) · 1143-1151
DOI: 10.1093/jnen/nlaf115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 10.10.2025. Verfasst von Ibrahim Choucair und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, United States. Hauptthemen laut MEDLINE: Alzheimer Disease, Specimen Handling. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer disease plasma biomarkers have emerged as minimally invasive, cost-effective tools for early diagnosis and disease monitoring yet their stability under common “real world” pre-analytical conditions remains incompletely characterized. We evaluated the stability of six plasma biomarkers, Aβ40, Aβ42, pTau181, pTau217, NfL, and glial fibrillary acidic protein (GFAP) using the Fujirebio Lumipulse G1200 platform. Plasma samples were initially collected from four healthy and cognitively unimpaired volunteers. Samples were stored under four conditions: room temperature (0-4 h), +4 °C (1-10 days), −20 °C (1-3 weeks), and −80 °C (4-8 weeks). In this pilot study, Aβ40 and Aβ42 remained generally stable. In contrast, pTau181 readings exhibited marked elevations in frozen samples, while pTau217 showed modest early fluctuations followed by significant decreases with prolonged storage. Next, we recruited 12 additional participants (six cognitively normal and six with mild cognitive impairment [MCI]), and their plasma samples were analyzed both fresh and after 4 weeks of storage at −80 °C. Among these participants, pTau181 readouts were significantly higher, and pTau217 were lower, in −80 °C frozen in comparison to never-frozen samples. These findings underscore the critical need for biomarker-specific sample workup and handling protocols and indicate that results for fresh plasma cannot be assumed to be the same as for frozen samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, United States.
- Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, United States.
- Department of Neuroscience, University of Kentucky, Lexington, KY, United States.
- Department of Neurology, Indiana University, Indianapolis, IN, United States.
- Stark Neurosciences Research Institute, Indiana University, Indianapolis, IN, United States.
- Department of Epidemiology & Environmental Health, University of Kentucky, Lexington, KY, United States.
ORCID-Profile: Ibrahim Choucair, Linda J Van Eldik, Jeffrey L Dage, Brian T Gold, Erin L Abner, Gregory A Jicha, Peter T Nelson
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Choucair, I., Lee, T. L., Van Eldik, L. J., Dage, J. L., Gold, B. T., Abner, E. L., Jicha, G. A., & Nelson, P. T. (2025). Storage-dependent variability in Alzheimer disease-related plasma biomarker results using the Fujirebio Lumipulse G1200 platform. Journal of Neuropathology & Experimental Neurology, 84(12), 1143-1151. https://doi.org/10.1093/jnen/nlaf115
Vancouver
Choucair I, Lee TL, Van Eldik LJ, Dage JL, Gold BT, Abner EL, et al. Storage-dependent variability in Alzheimer disease-related plasma biomarker results using the Fujirebio Lumipulse G1200 platform. Journal of Neuropathology & Experimental Neurology. 2025;84(12):1143-1151. doi:10.1093/jnen/nlaf115
BibTeX
@article{Choucair2025,
author = {Choucair, Ibrahim and Lee, Tiffany L and Van Eldik, Linda J and Dage, Jeffrey L and Gold, Brian T and Abner, Erin L and Jicha, Gregory A and Nelson, Peter T},
title = {Storage-dependent variability in Alzheimer disease-related plasma biomarker results using the Fujirebio Lumipulse G1200 platform},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2025},
volume = {84},
number = {12},
pages = {1143--1151},
doi = {10.1093/jnen/nlaf115}
}
EUVIMED